Table 1 Patient responses
Arm | ID | Age/ Gender | Histology | Stage | FLIPI/IPI | # of prior Tx | DC doses | Best response | Time to next treatment or event (months) |
|---|---|---|---|---|---|---|---|---|---|
A | LSA1 | 57M | Follicular | IVA | 2 | 1 | 2 | SD | 25 |
A | LSA2 | 56F | Follicular | IIIB | 4 | 2 | 2 | SD | 14 |
A | LSA3 | 69M | Follicular | IVA | 3 | 4 | 2 | PR | 22 |
A | LSA4 | 60F | Follicular | IVA | 3 | 3 | 2 | PR | 20 |
A | LSA5 | 64F | Follicular | IVA | 5 | 8 | 8 | PR | Not reached (12 mo at the time of abstract.) |
A | LSA6 | 81M | Follicular | IVA | 4 | 1 | 8 | SD | Not reached (9 mo at the time of abstract.) |
B | LSB1 | 60M | Follicular | IIIA | 3 | 1 | 4 | SD | 6.5 |
B | LSB2 | 62F | Marginal zone | IVAE | 4 | 6 | 4 | SD | 7.6 |
B | LSB3 | 65F | Follicular | IVA | 3 | 2 | 8 | CR | Not reached (13 mo at the time of abstract.) |
B | LSB4 | 31F | Follicular | IIIA | 2 | 0 | 8 | PR | Not reached (12 mo at the time of abstract.) |